Almac Group is a major global CDMO with 55+ years of experience, 7,800+ employees, and 18 facilities worldwide. The company provides end-to-end pharmaceutical services including API manufacture, formulation development, clinical trial supplies, commercial-scale manufacturing, packaging, serialization, and distribution, with additional capabilities in precision medicine diagnostics and drug discovery. Almac has contributed to approximately 50% of approved NMEs in the last 6 years.
API manufacturing, oral solid dose, potent compound handling, formulation development, clinical trial supply, commercial manufacturing, packaging and serialization, bioavailability enhancement, cold chain, precision medicine diagnostics
4 sites worldwide
No reviews available yet.
No documents available.